AAAAAA
Results: 26-33/33
Authors:
RIXE O
BENHAMMOUDA A
ANTOINE E
PETIT T
TOURANI JM
BOREL C
FRANKS C
KALIF B
MOUSSEAU M
THOMAS A
BENSFIA S
NIZRI D
SOUBRANE C
HERRERA A
BIZZARI JP
AUCLERC G
WEIL M
BANZET P
KHAYAT D
Citation: O. Rixe et al., CHEMOIMMUNOTHERAPY OF METASTATIC MELANOMA - CISPLATIN, INTERLEUKIN-2 AND IFN-ALPHA IN 91 PATIENTS, Pathologie et biologie, 42(10), 1994, pp. 1080-1081
Authors:
MOUAWAD R
ICHEN M
RIXE O
BENHAMMOUDA A
VUILLEMIN E
WEIL M
KHAYAT D
SOUBRANE C
Citation: R. Mouawad et al., STUDY OF IL-2 RECEPTOR EXPRESSION AFTER CHEMOIMMUNOTHERAPY IN PATIENTS TREATED FOR METASTATIC MALIGNANT-MELANOMA, Clinical and experimental immunology, 97(3), 1994, pp. 342-346
Authors:
SOUBRANE C
MOUAWAD R
ICHEN M
SUISSA J
BOREL C
VUILLEMIN E
BENHAMMOUDA A
BIZZARI JP
WEIL M
KHAYAT D
Citation: C. Soubrane et al., FOLLOW-UP OF SOLUBLE IL-2 RECEPTOR LEVEL IN METASTATIC MALIGNANT-MELANOMA PATIENTS TREATED BY CHEMOIMMUNOTHERAPY, Clinical and experimental immunology, 95(2), 1994, pp. 232-236
Authors:
SOUBRANE C
MOUAWAD R
ICHEN M
BENHAMMOUDA A
RIXE O
WEIL M
KHAYAT D
Citation: C. Soubrane et al., IL2 RECEPTOR EXPRESSION IN METASTATIC MAL IGNANT-MELANOMA PATIENTS TREATED BY BIOCHEMOTHERAPY, Bulletin du cancer, 81(11), 1994, pp. 970-971
Authors:
KHAYAT D
ANTOINE E
RIXE O
TOURANI JM
VUILLEMIN E
BOREL C
BENHAMMOUDA A
THILL L
FRANKS C
AUCLERC G
WEIL M
SOUBRANE C
BANZET P
Citation: D. Khayat et al., CHEMOIMMUNOTHERAPY OF METASTATIC MALIGNANT-MELANOMA THE SALPETRIERE HOSPITAL (SOMPS) EXPERIENCE, European journal of cancer, 29A, 1993, pp. 2-5
Authors:
KHAYAT D
BOREL C
TOURANI JM
BENHAMMOUDA A
ANTOINE E
RIXE O
VUILLEMIN E
BAZEX PA
THILL L
FRANKS R
AUCLERC G
SOUBRANE C
BANZET P
WEIL M
Citation: D. Khayat et al., SEQUENTIAL CHEMOIMMUNOTHERAPY WITH CISPLATIN, INTERLEUKIN-2, AND INTERFERON ALFA-2A FOR METASTATIC MELANOMA, Journal of clinical oncology, 11(11), 1993, pp. 2173-2180
Authors:
LEFEBVRE H
CONTESSE V
DELARUE C
SOUBRANE C
LEGRAND A
KUHN JM
WOLF LM
VAUDRY H
Citation: H. Lefebvre et al., EFFECT OF THE SEROTONIN-4 RECEPTOR AGONIST ZACOPRIDE ON ALDOSTERONE SECRETION FROM THE HUMAN ADRENAL-CORTEX - IN-VIVO AND IN-VITRO STUDIES, The Journal of clinical endocrinology and metabolism, 77(6), 1993, pp. 1662-1666
Authors:
SALEHIAN B
NIYONGABO T
SALMON D
VILDE JL
MELCHIOR JC
RIGAUD D
KAYAT D
SOUBRANE C
Citation: B. Salehian et al., TUMOR-NECROSIS-FACTOR AND RESTING ENERGY-EXPENDITURE DURING THE ACQUIRED-IMMUNODEFICIENCY-SYNDROME, The American journal of clinical nutrition, 58(5), 1993, pp. 715-716